Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.48 |
| ▸ | IDO1 | P14902 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CA12 | O43570 | 2/20 | 0.42 |
| ▸ | CA7 | P43166 | 2/20 | 0.42 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL812870 | 0.88 | CA2 (0.51) | CA2IDO1CA9CA1TXNRD1 | |
| SCHEMBL13159223 | 0.85 | MGLL (0.58) | CA2CA9CA1CA12CA7 | |
| SCHEMBL26719369 | 0.80 | RECQL (0.58) | CA2CA9CA1ALDH1A1CA12 | |
| SCHEMBL5216850 | 0.80 | TAAR1 (0.42) | CA2CA9CA1POLBALDH1A1 | |
| SCHEMBL7260130 | 0.80 | ALDH1A1 (0.45) | CA2CA9CA1POLBALDH1A1 | |
| SCHEMBL16207220 | 0.79 | CA2 (0.53) | CA2IDO1CA9CA1ALDH1A1 | |
| SCHEMBL260820 | 0.78 | KMT2A (0.61) | CA2CA9CA1TXNRD1ALDH1A1 | |
| SCHEMBL28197283 | 0.78 | CA2 (0.47) | CA2IDO1CA9CA1ALDH1A1 | |
| SCHEMBL27930070 | 0.78 | CA2 (0.57) | CA2IDO1CA9CA1CA12 | |
| SCHEMBL3250721 | 0.77 | ALDH1A1 (0.48) | CA2IDO1CA9CA1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110218218-A | Benzofuran derivative, preparation method and its application in medicine | 江苏恒瑞医药股份有限公司 | 2019-09-10 | — | — | CN | disclosed |
| CN-105390745-A | ENERGY STORAGE DEVICE | GS YUASA INT LTD | 2016-03-09 | — | — | CN | disclosed |
| CN-103262326-A | Non-aqueous secondary battery | HITACHI MAXELL | 2013-08-21 | — | — | CN | disclosed |
| EP-1167366-B1 | AMINE DERIVATIVES | DAIICHI SANKYO CO LTD (JP) | 2010-05-05 | — | — | EP | disclosed |
| US-6562849-B1 | Amine compound or pharmacologically acceptable salt thereof. These compounds are useful in the treatment and/or prophylaxis of diseases such as diabetes, hyperlipemia, arteriosclerosis, cancer, etc. | SANKYO COMPANY, LIMITED (JP) | 2003-05-13 | — | — | US | disclosed |
| US-20030078426-A1 | Amine derivative compounds | SANKYO COMPANY, LIMITED (JP) | 2003-04-24 | — | — | US | disclosed |
| EP-1167366-A1 | AMINE DERIVATIVES | Sankyo Company, Limited (JP) | 2002-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030078426-A1 | Amine derivative compounds | H1-10, APOB, PRMT1 | CA2 1149/4885IDO1 527/4885CA9 828/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.